<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03347240</url>
  </required_header>
  <id_info>
    <org_study_id>4996</org_study_id>
    <nct_id>NCT03347240</nct_id>
  </id_info>
  <brief_title>Neuroablation Versus Neuromodulation Techniques for Treatment of Secondary Dystonia</brief_title>
  <official_title>Comparative Study Between the Functional Outcomes of Neuromodulation and Neuroablation Techniques for Treatment of Secondary Dystonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The disability inflected by dystonia encouraged the development of many neurosurgical
      procedures.

      This is a prospective study included 120 patients suffering from intractable secondary
      dystonia.

      They were subjected to different neurosurgical treatments and were assessed through the
      follow up period
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Secondary dystonia are the syndromes that have dystonic symptoms due to brain insult which
      can be associated with neonatal encephalopathy syndromes, trauma, vascular injury,
      infections, demyelinations, or hereditary disorders associated with neurodegenerative
      process. The disability inflected by dystonia encouraged the development of many
      neurosurgical procedures in order to improve the quality of life of these patients.

      The aim of this study was to compare the outcomes of different Neuroablative and modulation
      techniques in treatment of secondary dystonia.

      Patients and methods This is a prospective study included 120 patients suffering from
      intractable secondary dystonia. Ablative techniques included the brain lesioning procedure
      and combined anterior and posterior lumbar rhizotomy (CAPR). Modulation techniques included
      deep brain stimulation (DBS) and intrathecal baclofen therapy (ITB). Patients with focal
      dystonia were included in the Botulinum toxin injection group. Patients with generalized
      dystonia were included in either of the brain lesioning or the deep brain stimulation, and
      patients with predominant affection of both lower limbs were included in either of the (CAPR)
      or the (ITB) groups.

      Assessment measures included the evaluation of the muscle tone, range of motion, and the
      Burke-Fahn-Marsden dystonia rating scale through a follow up period of one year.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2013</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Burke-Fahn-Marsden dystonia rating scale</measure>
    <time_frame>1 year</time_frame>
    <description>Dystonia rating scale Higher scores means a worse condition of the disease, while low scores indicate a less involvement of the body</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Ashworth scale</measure>
    <time_frame>1 year</time_frame>
    <description>Muscle tone scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel index</measure>
    <time_frame>1 year</time_frame>
    <description>Disability score</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Secondary Dystonia</condition>
  <arm_group>
    <arm_group_label>Brain lesioning group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stereotactic lesioning of the thalamus or gloves pallidus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined rhizotomy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combined anterior and posterior lumbosacral rhizotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep brain stimulation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral globus pallidus internus deep brain stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intra-thecal Baclofen infusion therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-thecal infusion pump</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Brain Lesioning</intervention_name>
    <description>Stereotactic radiofrequency lesioning of the pallidum or thalamus</description>
    <arm_group_label>Brain lesioning group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined anterior and posterior lumbosacral rhizotomy</intervention_name>
    <description>Combined anterior and posterior lumbosacral rhizotomy</description>
    <arm_group_label>Combined rhizotomy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>Bilateral DBS</description>
    <arm_group_label>Deep brain stimulation group</arm_group_label>
    <other_name>DBS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intra-thecal baclofen infusion</intervention_name>
    <description>Intra-thecal Baclofen infusion</description>
    <arm_group_label>Intra-thecal Baclofen infusion therapy</arm_group_label>
    <other_name>ITB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  secondary dystonia of previous etiologies

        Exclusion Criteria:

          -  patients who are not candidate for anaesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walid A Abdel Ghany, MD</last_name>
    <role>Study Director</role>
    <affiliation>Associate professor</affiliation>
  </overall_official>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohamed Nada</investigator_full_name>
    <investigator_title>Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

